ORIGINAL RESEARCH
Published on 09 Aug 2022
Neuronal MD2 induces long-term mental impairments in septic mice by facilitating necroptosis and apoptosis
doi 10.3389/fphar.2022.884821
- 3,460 views
- 8 citations
- Frontiers in Neuroscience
- Neuropharmacology
- Research Topics
- Neuropharmacological Targets for Depressive Disorders and Seizures
Neuropharmacological Targets for Depressive Disorders and Seizures
5,478
Total downloads
20k
Total views and downloads
Submit your idea
Select the journal/section where you want your idea to be submitted:
Articles
CASE REPORT
Published on 31 Mar 2022
Case Report: Vortioxetine in the Treatment of Depressive Symptoms in Patients With Epilepsy—Case Series
doi 10.3389/fphar.2022.852042
- 5,847 views
- 3 citations
ORIGINAL RESEARCH
Published on 08 Mar 2022
Hippocampus RNA Sequencing of Pentylenetetrazole-Kindled Rats and Upon Treatment of Novel Chemical Q808
doi 10.3389/fphar.2022.820508
- 2,143 views
- 5 citations
ORIGINAL RESEARCH
Published on 23 Feb 2022
Decreased Risk of Anxiety in Diabetic Patients Receiving Glucagon-like Peptide-1 Receptor Agonist: A Nationwide, Population-Based Cohort Study
doi 10.3389/fphar.2022.765446
- 5,533 views
- 17 citations
ORIGINAL RESEARCH
Published on 18 Nov 2021
Exogenous Carbon Monoxide Produces Rapid Antidepressant- and Anxiolytic-Like Effects
doi 10.3389/fphar.2021.757417
- 2,116 views
- 7 citations
Published in
Frontiers in Neuroscience
- Neuropharmacology
Participating Journals
Frontiers in Neurology
NeuropharmacologyOffline
- 2.7 impact factor
- 4.9 citescore
Frontiers in Pharmacology
- 4.4 impact factor
- 7.8 citescore
Frontiers in Psychiatry
NeuropharmacologyOffline
- 3.2 impact factor
- 6.2 citescore
Impact
- 20kTopic views
- 14kArticle views
- 5,478Article downloads